Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/2010
03/30/2010US7687606 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil.
03/30/2010US7687605 Antibody comprising a human heavy chain framework sequence, three heavy chain hypervariable region sequences and three light chain hypervariable region sequences; modulating biological activity of integrins containing the beta7 subunit
03/30/2010US7687464 fusion proteins; membrane proteins; cancer, metastasis
03/30/2010US7687242 KID31 and antibodies that bind thereto
03/30/2010US7687063 monoclonal antibodies, hybridomas; immunoglobulins, fab fragments
03/30/2010US7687061 Method of modulating the activity of functional immune molecules to Her-2
03/30/2010US7687060 Method for the treatment or prophylaxis of tuberculosis
03/30/2010CA2681287A1 Antibodies for determining the prothrombin fragment f2/f1+2 in a homogeneous immunoassay
03/30/2010CA2372633C Staphylococcus aureus antigen-containing whole cell vaccine
03/30/2010CA2241604C Mesothelium antigen and methods and kits for targeting it
03/30/2010CA2170523C Cloned glutamic acid decarboxylase
03/30/2010CA2162150C Germline mutations in the mts gene and method for detecting predisposition to cancer at the mts gene
03/30/2010CA2155004C Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
03/25/2010WO2010033923A2 Genus-wide chlamydial peptide vaccine antigens
03/25/2010WO2010033866A2 Monoclonal antibodies for cspg4 for the diagnosis and treatment of basal breast carcinoma
03/25/2010WO2010033757A1 Nmda receptor modulators and uses thereof
03/25/2010WO2010033736A1 Novel compositons and methods for treating ige-mediated disorders
03/25/2010WO2010033667A2 Wstf regulates the dna damage response of h2a.x via novel tyrosine kinase activity
03/25/2010WO2010033229A2 Methods and vectors for display of molecules and displayed molecules and collections
03/25/2010WO2010033031A1 Multifunctional linker protein containing an antibody against hemagglutinin, a conserved influenza antigen and an immunostimulating carrier binding domain
03/25/2010WO2010032899A2 Eno1-specific human antibody
03/25/2010WO2010032786A1 Transgenic animal
03/25/2010WO2010032061A1 Antibodies against sonic hedgehog homolog and uses thereof
03/25/2010WO2010032060A1 Antibodies directed to dll4 and uses thereof
03/25/2010WO2010032059A2 Targeted binding agents directed to cd105 and uses thereof
03/25/2010WO2010031749A1 Compositions and methods for detecting tlr3
03/25/2010WO2010031551A2 Monoclonal antibodies for treatment of cancer
03/25/2010WO2010031312A1 Regulation of nitrogen starvation response
03/25/2010WO2010031168A1 HETERO-MULTIVALENT BINDING AGENTS FOR MEMBERS OF THE TGFβ SUPERFAMILY
03/25/2010WO2010016760A3 Immunogenic composition for the treatment of e. faecium infection
03/25/2010WO2010014915A3 Novel peptides for use in transfection
03/25/2010WO2010014854A3 Antibodies that neutralize botulinum neurotoxins
03/25/2010WO2010006454A3 Functionalized polypeptides
03/25/2010WO2009155060A3 Anti-pyk2 antibodies
03/25/2010WO2009137577A3 Leishmania vaccine using sand fly salivary immunogen
03/25/2010WO2009129247A3 Sequence diversity generation in immunoglobulins
03/25/2010WO2009129173A4 Methods, antibodies and kits for detecting cerebrospinal fluid in a sample
03/25/2010WO2009121004A3 Neutralizing molecules to viral antigens
03/25/2010US20100077498 Compositions and methods for blood-brain barrier delivery in the mouse
03/25/2010US20100077497 Ip-10 antibodies and their uses
03/25/2010US20100077496 MO-1, A Gene Associated With Morbid Obesity
03/25/2010US20100076179 Antibodies to mammalian cytokine-like factor 7
03/25/2010US20100076178 Dual Variable Domain Immumoglobulins and Uses Thereof
03/25/2010US20100076177 Hybrid antibodies
03/25/2010US20100076174 ErbB Interface Peptidomimetics And Methods Of Use Thereof
03/25/2010US20100075891 Novel polynucleotides encoding polypeptides and methods using same
03/25/2010US20100075412 T1r taste receptors and genes encoding same
03/25/2010US20100075402 DNA coding for polypeptide fusion
03/25/2010US20100075394 Method of Crosslinking Two Objects of Interest
03/25/2010US20100075378 Moraxella catarrhalis basb115 polypeptides
03/25/2010US20100075343 Novel peptides
03/25/2010US20100074991 Novel oxidoreductases and uses thereof
03/25/2010US20100074923 Purification of bacterial antigens
03/25/2010US20100074916 Avian influenza vaccine
03/25/2010US20100074910 Achievement of a high therapeutic index through molecular imaging guided targeted drug treatment
03/25/2010US20100074908 Human synthetic single-chain antibodies directed against the common epitope of mutant P53 and their uses
03/25/2010US20100074906 Antibodies Specific for Varicella Zoster Virus
03/25/2010US20100074902 Methods for human allografting
03/25/2010US20100074901 Human anti-amyloid antibodies, compositions, methods and uses
03/25/2010US20100074900 Prostaglandin e2 dual variable domain immunoglobulins and uses thereof
03/25/2010US20100074894 Pharmaceutical composition containing antibodies directed against the herv-w envelope
03/25/2010US20100074893 ECM-Complex Antibody Compositions and Methods of Use
03/25/2010US20100074892 Monoclonal Antibodies That Neutralize Anthrax Protective Antigen (PA) Toxin
03/25/2010US20100074890 Methods for identifying hcv protease inhibitors
03/25/2010US20100074887 Methods for Treating and Diagnosing Fibrotic and Fibroproliferative Diseases
03/25/2010US20100074845 Enhanced sensitivity carbon nanotubes as targeted photoacoustic molecular imaging agents
03/25/2010US20100074841 Compositions Against Cancer Antigen LIV-1 and Uses Thereof
03/25/2010CA2774336A1 Genus-wide chlamydial peptide vaccine antigens
03/25/2010CA2744523A1 Methods and vectors for display of molecules and displayed molecules and collections
03/25/2010CA2740628A1 Nmda receptor modulators and uses thereof
03/25/2010CA2737758A1 Monoclonal antibodies for cspg4 for the diagnosis and treatment of basal breast carcinoma
03/25/2010CA2737667A1 Targeted binding agents directed to cd105 and uses thereof
03/25/2010CA2737212A1 Dendritic cell modulatory molecule
03/25/2010CA2737074A1 Methods for treating progressive multiple sclerosis
03/25/2010CA2736511A1 Novel compositions and methods for treating ige-mediated disorders
03/25/2010CA2736198A1 Novel antibody formulation
03/25/2010CA2735900A1 Antibodies directed to dll4 and uses thereof
03/25/2010CA2734330A1 Antibodies against sonic hedgehog homolog and uses thereof
03/25/2010CA2732594A1 Monoclonal antibodies for treatment of cancer
03/25/2010CA2726845A1 Antibodies with altered binding to fcrn and methods of using same
03/25/2010CA2722794A1 Multifunctional linker protein containing an antibody against hemagglutinin, a conserved influenza antigen and an immunostimulating carrier binding domain
03/24/2010EP2166021A1 Monoclonal antibodies for treatment of cancer
03/24/2010EP2165715A1 Therapeutic agent for cancer, and method for treatment of cancer
03/24/2010EP2165714A1 Humanized antibodies recognizing the beta-amyloid peptide
03/24/2010EP2165199A1 Detection of cell surface binding molecules using a phage display blocking assay
03/24/2010EP2164992A1 Compositions and methods for binding lysophosphatidic acid
03/24/2010EP2164989A1 Targeted carriers for intracellular drug delivery
03/24/2010EP2164961A2 Sequence based engineering and optimization of single chain antibodies
03/24/2010EP2164875A1 Intranuclear protein transduction through a nucleoside salvage pathway
03/24/2010EP2164874A1 Chimeric and humanized anti-cd44 antibodies that mediate cancer cell cytotoxicity
03/24/2010EP2164873A1 Stable igg4 antibodies
03/24/2010EP2164872A1 Novel fully human anti-vap-1 monoclonal antibodies
03/24/2010EP2164871A2 Anti-cd20 therapeutic compositions and methods
03/24/2010EP2164870A1 Polypeptides and polynucleotides for artemin and related ligands, and methods of use thereof
03/24/2010EP2164869A2 Antigen-binding proteins targeting s. aureus orf0657n
03/24/2010EP2164868A1 Engineered rabbit antibody variable domains and uses thereof
03/24/2010EP2164867A2 Polypeptides, antibody variable domains & antagonists
03/24/2010EP2164866A1 Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
03/24/2010EP2164863A2 Methods of delivery of molecules to cells using a ricin subunit and compositions relating to same
03/24/2010EP2164862A1 Clostridial toxin netb
1 ... 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 ... 1494